Heparin Market - Top Companies and Manufacturers

  • Report ID: 3402
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Companies Dominating the Heparin Landscape

top-features-companies
    • Aspen Holdings
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Opocrin S.p.A.
    • LEO Pharma Inc.
    • Baxter
    • Dr. Reddy’s Laboratories Ltd.
    • Pfizer Inc.
    • B. Braun Medical Inc.
    • Bioiberica S.A.U.
    • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
    • Fresenius Kabi Canada

Browse Key Market Insights with Data Illustration:

In the News

  • Amcor Group GmbH has launched its latest OmniPack PET bottles to meet the requirements for e-commerce-ready packaging. Amcor has designed a family of stock PET bottles that help co-packers to meet demanding requirements for e-commerce-ready packaging.

  • ALPLA Group along with Voslaur has entered into a partnership to develop a new PET bottle for the Austrian market that will reduce the carbon footprint by 30% and reduces bottle weight by almost 90% in comparison to reusable substitute made up of glass.


Author Credits:  Radhika Pawar


  • Report ID: 3402
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of heparin is estimated at USD 10.83 Billion.

The heparin market size was valued at USD 10.43 Billion in 2023 and is expected to cross USD 18.03 Billion by the end of 2036, expanding at more than 4.3% CAGR during the forecast period i.e., between 2024-2036. The higher number of patients with cancer, increased prevalence of chronic disease, rising cases of thromboembolism, and road accidents are a few factors likely to propel the market growth.

North America is likely to dominate majority industry share by 2036, propelled by higher number of people developing chronic kidney diseases, followed by surging healthcare expenditure.

Aspen Holdings, Opocrin S.p.A., LEO Pharma Inc., Baxter, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., B. Braun Medical Inc., Bioiberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying